This raises the possibility that vascular activation by viral infection or S protein, along with pre-existing brain diseases (which are more common in older individuals) places them at greater risk of neurological sequelae of PASC (Agrawal et al., 2022). The gene discussed is PROS1; the disease is long COVID-19.